cancer stem cells , CSCs (Abkürzung)

Cancer stem cells differ in that they have lost control over their own population size.

In 1994, Nature published his paper which described how cancer stem cells grow slowly.

Several research groups are investigating cancer stem cells and their potential to cause tumors.

Oct-4 has also been implicated as a marker of cancer stem cells.

But with better markers, he said, it may turn out that a much smaller proportion are true cancer stem cells.

Some experts believe that cancer stem cells are at the core of every metastasis.

In 2010, he discovered a new marker for detection of breast cancer stem cells.

But companies may hold back from broader investment in the field until the basic biology of cancer stem cells is better understood.

Biologists are not yet sure how cancer stem cells are generated.

Seneca Valley virus has been proposed to attack cancer stem cells.

The origin of cancer stem cells is still an area of ongoing research.

This is because cancer stem cells are isolated from end-stage tumors.

The evolutionary processes do not cease when a population of cancer stem cells arises in a tumor.

With that caveat mentioned, various theories define the origin of cancer stem cells.

Others are looking at cancer stem cells.

CD133 is shown to be a marker of tumor-initiating or cancer stem cells in neuroblastoma.

Source of cancer stem cells' resistance to radiation explained on YouTube.

How closely similar are dormant cancer cells and cancer stem cells?

The discovery is particularly valuable because cancer stem cells cause the out-of-control growth that makes malignant tumors so deadly.

Boockvar and his research team focus on cancer stem cells and their relationship to malignant tumors of the brain.

Some researchers believe that the key to finding a cure for cancer is to inhibit proliferation of cancer stem cells.

These cells have been termed cancer stem cells to reflect their stem-like properties.

Making embryonic stem lines from cancer patients could help identify and focus on cancer stem cells.

In mice, pretreatment with the diabetes drug prevented the otherwise dramatic ability of human breast cancer stem cells to form tumors.

Human cancer stem cells from Glioblastoma multiforme.